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Extracellular serine proteases of the plasminogen activator family (tissue-type plasminogen activator (tPA) and urokinase-type
plasminogen activator (uPA) may modulate synaptic adhesion and associate with learning behavior. Psychostimulants strongly induce
their expression in the mesolimbic dopaminergic pathway, but cocaine preferentially induces uPA, whereas morphine and amphetamine
preferentially induce tPA. tPA-expressing animals displayed enhanced conditional place preference (CPP) for amphetamine compared
with uPA-overexpressing animals. Thus, modulation of the plasminogen system in the brain might be a potential target against drugs of
abuse. In the present study, we aim to identify whether tPA is involved in the acquisition/learning phase or in the expression/retrieval
phase of conditioned drug preference. For this purpose, animals were injected with lentiviruses expressing or silencing tPA in the NAc
and place preference was assessed. We found that tPA expression is associated with acquisition of place preference and animals
overexpressing tPA spend 487% of the time in the drug-associated compartment, compared with 60% for control animals. When
ectopic expression of tPA has been inhibited by doxycycline during acquisition, animals do no more associate the environment with the
drug. Suppression of endogenous tPA expression in animals treated with LV-siRNA fully suppresses place preference, and these animals
appear to avoid the drug-associated box. tPA overexpression delays extinction, but priming with low doses of amphetamine reinstates
place preference even after full extinction. Together, these data clearly indicate that tPA plays an important role in acquisition of
amphetamine-induced CPP, but its role in CPP expression does not seem important.
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INTRODUCTION
Activity-dependent synaptic plasticity and remodeling of
the mesolimbic dopaminergic system play a crucial role in
the development of drug dependence (Nestler, 2001).
Previous studies have shown that psychostimulants strongly
induce urokinase-type plasminogen activator (uPA) expres-
sion in the mesolimbic dopaminergic pathway, which has a
major role in drug-mediated behavior and plasticity
changes (Bahi et al, 2004a, 2006; Bahi and Dreyer, 2007).
Extracellular serine proteases of the plasminogen activator
family may modulate synaptic adhesion and associate with
long-term potentiation and learning behavior. Furthermore,
overexpression of uPA in the nucleus accumbens (NAc)
shell strongly affects cocaine-induced conditional place
preference (CPP) and delays extinction (Bahi and Dreyer,
2007). The NAc plays a central role in reward and is also an
important structure regarding learning and memory (Dong
et al, 2007; Gerdjikov et al, 2007; Ferretti et al, 2007). On the
other hand, tissue-type plasminogen activator (tPA) is
abundantly expressed in the central nervous system and
contributes to the regulation of numerous aspects of
synaptic plasticity and remodeling (Qian et al, 1993;
Bu et al, 1994; Seeds et al, 1995; Hayden and Seeds, 1996;
Davies and Silver, 1998). tPA participates in neurite
outgrowth and neuronal development by cleaving proteins
of the extracellular matrix and potentially forming a path
for extending processes (Wu et al, 2000; Jacovina et al,
2001). It may serve as a potential mediator of L-LTP and
may be involved in activity-related formation of perforated
synapses in the hippocampus (Neuhoff et al, 1999).
A role for tPA in drug addiction has been suggested, since
it enhances amphetamine and morphine behavioral sensi-
tization (Nagai et al, 2004, 2005). Furthermore, tPA-
knockout mice are not sensitized when tPA is absent and,
if recombinant tPA is given back, they display a CPP score
almost identical to that of wild-type mice; in addition, at low
doses of cocaine, tPA-knockout mice showed enhanced
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locomotor activity when compared with their wild-type
littermates, and displayed greater behavioral sensitization
than the wild types (Ripley et al, 1999). Additionally,
the reinforcing effects of morphine were reduced in
tPA-knockout mice. Therefore, it has been suggested that
modulation of the tPA system in the brain might be a
potential target against drugs of abuse (Yan et al, 2007).
In previous studies, we presented further evidence for a
significant function of extracellular proteases, tPA and uPA,
in addiction and drug-related synaptic plasticity (Bahi and
Dreyer, 2007). Our data suggested a differential role of
plasminogen activators in this context. Psychostimulants
induce both tPA and uPA in acute and chronic drug
delivery, but cocaine preferentially induces uPA, whereas
morphine and amphetamine preferentially induce tPA (Bahi
and Dreyer, 2007). We showed that plasminogen activators
tPA and uPA induce distinct behaviors. uPA-expressing
animals displayed enhanced CPP for cocaine compared with
tPA-overexpressing animals. By contrast, tPA-expressing
animals displayed greater place preference compared with
uPA-overexpressing animals when administered ampheta-
mine or morphine (Bahi and Dreyer, 2007). These results
could be interpreted according to differential pattern of
activation and downstream targets. Also, when uPA was
inhibited during the acquisition phase, animals no longer
associated the environment with the drug and cocaine-
induced place preference and reinstatement was largely
dependent on active extracellular uPA. As we had proposed
(Bahi and Dreyer, 2007), these observations suggest a
putative role for inhibitors of specific plasminogen activa-
tors as useful tools for the treatment of addiction.
In the present study, we further investigated the role of
the plasmin system in the expression of drug sensitization
through emphasis on the role of tPA in amphetamine
related behavior. The aim was to identify whether tPA is
involved in the acquisition/learning phase or in the
expression/retrieval phase of conditioned drug preference.
For this purpose, animals were injected with lentiviruses
expressing or silencing tPA in the NAc and place preference
was assessed. The major finding was that tPA expression
enhanced acquisition, but not expression, of amphetamine-
induced CPP.
MATERIALS AND METHODS
Animals
Animals used in this experiment were male Wistar rats
weighing 220–250 g that were obtained from Janvier
(Genest-St-Isle, France). All animal experiments were
carried out in accordance with the guidelines and regula-
tions for Animal Experimentation, BAG, Bern, Switzerland.
Three animals were housed per clear plastic cage with wire
grid lids. Access to food and water was ad libitum, with
illumination set on a 12-h light : 12-h dark cycle (light off at
0700 hours).
Lentivirus Construction of tPA-Expressing Lentivirus
(LV-tPA), LV-GFP and LV-siRNAs
Using total RNA from cocaine-treated rat brain, the tPA
cDNA was amplified and 6His-tagged by reverse transcription
using M-MLV-RT (Invitrogen, Switzerland) following the
manufacturer’s instructions. We performed PCR amplifica-
tion using the following set of rat tPA-specific primers:
forward primer (with BamHI) 50-CGCGGGATCCATGAAGGG
AGAGCTGTTGTGC-30 and reverse primer (with XhoI): 50-GC
CGCTCGAGTTAATGATGATGATGATGATGTTGCTTCATG
TTGTCTTGAAT-30. The cDNA was then digested with
BamHI and XhoI and cloned into similar sites in the lentiviral
system transfer vector pTK431. A control vector construct, in
which green fluorescent protein (GFP) expression is regulated
by a tetracycline-inducible promoter, was generated by
cloning a BamHI/BglII DNA fragment containing the GFP
gene into a BamHI site in pTK431 (Bahi et al, 2004a, b,
2005a, b, 2006; Bahi and Dreyer, 2007).
To silence tPA expression in vivo, three targets were
designed according to the rat tPA mRNA sequence
(GenBank accession number M23697). The following targets
within the tPA sequence were selected: first target, 2–25;
second target, 1650–1673; third target, 733–756. an XhoI
restriction site was 30 added to each oligo. Using pSilencer
1.0-U6 (Ambion, UK) as a template and a U6 promoter-
specific forward primer containing BamHI (in bold)
restriction site, GCGGATCCCGCTCTAGAACTAGTGC, each
small interfering RNA (siRNA) target was added to the
mouse U6 promoter by PCR (each target contains a
30-specific, U6 promoter-specific primer). The PCR condi-
tions were highly stringent to avoid mutations within the
targets. The following PCR program was performed: 120 s at
941C (initial denaturation) followed by 941C for 45 s, 641C
for 45 s, and 721C for 45 s, repeated over 35 cycles. The PCR
reaction contains 4% dimethylsulfoxide (Sigma, Switzer-
land). The PCR product was digested with BamHI and XhoI,
cloned into similar sites in pTK431, and sequenced to verify
the integrity of each construct.
After cloning and sequencing, all plasmids were
CsCl2-purified. Vesicular stomatitis virus G-pseudotyped
lentiviruses were produced by the transient calcium
phosphate cotransfection of human embryonic kidney
293T (HEK293T) cells with pTKs vectors together with
pMDG-VSV-G and pDNRF as described previously (Naldini
et al, 1996; Bahi et al, 2004a, b, 2005a, b, 2006; Bahi and
Dreyer, 2007). Lentiviral vector quantifications were
performed according to the p24 ELISA kit (KPL, USA) in
accordance with the manufacturer’s instructions.
Surgery
All surgical procedures were performed as previously
described (Bahi et al, 2004a, b, 2005a, b, 2006; Bahi and
Dreyer, 2007). Briefly, rats were anesthetized with a mix
of ketamine/xylazine (100mg/kg/10mg/kg, i.p.), and
then, using a stereotactically guided 5-ml Hamilton syringe,
2 ml per site of concentrated lentiviral solution (approxi-
mately 200 000 ng of p24 antigen per milliliter) was
bilaterally injected into the NAc at the following coordi-
nates: anterior, + 1.4; lateral, ±1.6; ventral, 6.8; Paxinos
and Watson (1998). The rate of infusion was 1 ml/min, and
the needle was left in place for an additional 5min prior to
withdrawal. After surgery, animals were injected subcuta-
neously with 5ml of pre-warmed saline to avoid animal
dehydration, and were allowed 7 day to recover prior to
experimentation.
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CPP Test
CPP was performed as described previously (Mueller and
Stewart, 2000). Briefly, in the pre-conditioning period, rats
(n¼ 9) were allowed to move freely between two inter-
connected compartments (consisting of either wire grid or
mesh floor) daily for 20min for 3 days (days 1–3). On day 3,
the amount of time spent in each chamber was monitored
and used to assess unconditioned preference. Prior to
conditioning, the rats were divided into two groups (n¼ 18
per group). The first group of animals received water
supplemented with 5% sucrose, and the second group of
animals received water supplemented with 5% sucrose and
0.02% doxycycline only during conditioning ‘acquisition’
(days 3–9). During the conditioning phase, the rats were
injected on days 4, 6, and 8 with amphetamine (5mg/kg,
i.p.; n¼ 9 per group) and immediately confined in the floor-
mesh box for 20min. On days 5, 7, and 9, the rats were
injected with 0.9% saline (1ml/kg) and placed in the wire
grid chamber for 20min. During the conditioning phase,
passage between chambers was blocked by a guillotine door.
On day 10, the post-CPP test was performed without drug
treatment and without doxycycline. Animals were placed in
the interconnecting passage between the two chambers,
with the guillotine door removed, and were allowed free
access to the entire setup. The time spent in each chamber
was measured for 20min. Drug-induced place preference
was expressed by Post vs Pre, which was calculated as
follows: [(Post value)(Pre value)], where Post and
Pre values indicate the difference in time spent at the
drug-conditioning site during post-conditioning and pre-
conditioning periods, respectively.
Extinction by repeated testing. After conditioning and
following the initial CPP test, rats (n¼ 9) underwent 20-min
tests daily for 10 days. No injections were performed during
this extinction period.
Reinstatement by amphetamine priming after extinction.
After conditioning and following the initial CPP test, rats
(n¼ 9) underwent 20-min tests daily for 10 days. No
injections were performed during this extinction period.
The animals did not receive amphetamine during this
period. Following this period of extinction, all animals
(n¼ 9) received a priming injection of 0.9% saline (1ml/kg)
tested for CPP, or were injected with amphetamine (2mg/
kg, i.p.) immediately before the final test for CPP.
Maintenance of the CPP. After CPP test, rats (n¼ 9)
underwent a 5-week period of non-exposure to the test
apparatus to determine whether retention of CPP would be
maintained. During this time, animals were not injected and
not tested, but were kept in their home cages. After this
period, rats were placed in the apparatus and provided free
access to both the compartments over a 20-min period.
Immunohistochemistry
Brain section staining was performed according to pre-
viously published procedures (Bahi et al, 2004a; Bahi and
Dreyer, 2007). Briefly, rat brains were rapidly removed and
frozen in isopentane at 301C for 3min and kept at 251C.
Coronal sections were cut at 14 mm with a cryostat (Leitz),
placed on gelatinized glass slides, and air-dried at room
temperature for 20min. Antigens were localized using the
avidin–biotin–peroxidase technique. Slices were fixed in 4%
PFA for 15min, and washed three times with 1 PBS.
Endogenous peroxidase activity was quenched with 2%
hydrogen peroxide in water (H2O2) for 40min at room
temperature. Nonspecific binding was blocked for 30min at
RT in 1 PBS containing 1% bovine serum albumin, 1%
Triton X-100, and 3% normal goat serum. Sections were
then rinsed and incubated overnight with mouse anti-
histidine antibody (MCA1396, 1:12 000; Serotec) diluted in
1 PBS containing 1% Triton X-100 and 1% normal goat
serum. Sections were then washed three times with 1 PBS
and incubated with the biotinylated secondary antibody
(goat anti-mouse immunoglobulin G, 1:500; Vector Labora-
tories, Burlingame, CA) for 45min at room temperature.
Sections were rinsed three times for 5min in 1 PBS at
room temperature, followed by incubation in avidin–biotin
complex (Vector Laboratories) in 1 PBS solution. After
three rinses in 1 PBS, all sections were developed in
0.025% 3–30 diaminobenzidine tetrahydrochloride plus
0.02% H2O2 for 10–15min. Sections were then dehydrated,
mounted in permanent medium (Eukitt), and examined
with a Zeiss light microscope.
Statistical Analysis
All data were expressed as means±SEM and analyzed using
SPSS v11 software. In the analysis of CPP, statistical analysis
was performed using an analysis of variance. First, an over-
all F-test analysis was performed to identify significant
differences among any of the group means. In case of
statistically significant F-ratio scores (po0.05), a second
analysis using Tukey’s test has been carried out, where sets
of two groups at a time were compared to specifically
determine significance differences. Acceptable significance
level was set at po0.05.
RESULTS
LV-tPA Enhances Amphetamine-Induced Place
Preference
Twelve groups of animals were prepared. Four groups
consisted of animals injected with LV-GFP into the NAc.
Another set of four groups of animals was injected with LV-
tPA into the Nac, and a third set of four groups was infected
with a lentivirus expressing siRNAs silencing locally
endogenous tPA expression in the NAc. Two groups of
each set were fed doxycycline, and the other groups of each
set were fed 5% sucrose without doxycycline. Animals were
then trained for CPP: rats were habituated for 3 days and
tested for pre-conditioning, then trained for 6 days for CPP,
and then tested for post-conditioning. Some groups were
trained with saline injections, while others were treated with
amphetamine injections, during the conditioning phase of
CPP training. Thereafter, place preference was evaluated.
The data from this experiment are summarized in
Figure 1. Before conditioning (at day 3), animals displayed
no place preference for the two compartments (Figure 1a
and b). Under all conditions, CPP was unbiased, since
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during this preconditioning phase, rats spent the same
amount of time in both the chambers (data not shown;
F(11,60)¼ 0.853; p40.589). After conditioning (at day 10), no
place preference was observed in all six groups injected with
saline during conditioning (Figure 1a, F(5,30)¼ 0.529;
p40.735). Upon amphetamine conditioning, GFP-treated
animals displayed a slight preference for the drug-paired
box and spent 25% more time in this compartment
(Figure 1a, F(5,30)¼ 134.986; po0.0001). Further, animals
stereotactically injected with LV-tPA, overexpressing tPA in
the NAc, displayed much stronger preference for the drug-
associated compartment, where they spent 487% of the
time (Figure 1a, F(5,30)¼ 134.986; po0.0001). In contrast,
when tPA expression was suppressed in the NAc, in animals
injected with LV-siRNAs, place preference was reduced
even below the levels of the GFP control animals (Figure 1a,
F(5,30)¼ 134.986; po0.0001).
Other groups of animals were infected with the same
lentiviruses into the NAc, but were fed doxycycline during
acquisition. Thereafter, at the end of the training period (day
10), doxycycline was removed from the drinking water and
animals were given doxycyline-free water. Under these
conditions, control animals, treated with LV-GFP, displayed
no significant CPP score difference compared with control
animals fed given the normaldoxycycline-free regimen
throughout (compare LV-GFP in Figure 1a and b, F(5,30)¼
134.986; p40.98). By contrast, in animals treated with
LV-tPA the CPP score upon amphetamine conditioning
was strongly reduced in comparison with animals given the
normal regimen (F(5,30)¼ 134.986; po0.0001), and, under
these conditions, LV-tPA animals still displayed difference in
CPP compared with LV-GFP-treated animals (F(5,30)¼ 86.763;
po0.004; Figure 1b). Furthermore, doxycycline feeding had
no effect on LV-siRNA-treated animals (Figure 1b,
F(5,30)¼ 9.963; p40.663). Therefore, avoiding overexpression
of tPA during the acquisition phase of place preference
suppresses amphetamine-induced place preference.
LV-tPA-Mediated Delayed Extinction of Amphetamine-
Induced Place Preference
Animals injected with either LV-GFP, LV-tPA, or LV-
siRNAs were trained with daily injections of amphetamine
or saline as described under Materials and Methods. Finally,
after CPP monitoring on day 10, they were placed daily into
the setup for 20min/day for 12 days, but drug was not
injected during this extinction period. As shown in Figure 2,
saline-treated animals displayed no place preference and a
stable CPP score throughout the four time points con-
sidered for the statistical analysis, even if animals have been
fed doxycycline during the acquisition period (Figure
2a and b, day 1, F(5,30)¼ 1.19; p40.337, or Figure 2a and b,
day 7, F(5,30)¼ 0.66; p40.657, and Figure 2a and b, day 12,:
F(5,30)¼ 0.329; p40.892). No difference was observed
between the beginning and the end of the CPP extinction
period (Figure 2a and b, day 1 vs day 12, F(5,30)¼ 0.349;
p40.849).
By contrast, in groups injected with amphetamine
during the acquisition period, strong place preference
and CPP score were induced among tPA-treated animals
(Figure 1b, F(5,30)¼ 134.986; po0.0001). During extinction,
tPA-injected animals still display higher CPP score at
day 1 (Figure 2a0, F(5,30)¼ 260.475; po0.0001) or day 7
(Figure 2a0, F(5,30)¼ 56.695; po0.0001), and large
differences between days 1 and 12 (Figure 2a0, F(5,30)¼
110.339; po0.0001). However, no difference was observed
at day 12 between all the groups. LV-GFP-treated animals,
as well as LV-siRNA-treated animals, also displayed
extinction upon drug withdrawal (F(11,60)¼ 74.445;
po0.0001). At the end of the withdrawal period, all
groups of animals displayed no preference anymore for
the drug-associated compartment (Figure 2a0, day 12,
F(5,30)¼ 1.531; p40.210). Clearly, GFP-treated animals, as
well as siRNA-treated animals, were unable to distin-
guish between the two compartments already 7 days after
the CPP test (F(3,20)¼ 0.247; p40.862, and F(3,20)¼ 1.602;
p40.22, respectively), whereas tPA-treated animals
displayed a longer extinction latency (F(3,20)¼ 95.544;
po0.0001), which lasted for approximately 12 days, in
part due to the fact that place preference was much higher
initially in this group. The same observations could be
made with animals fed doxycycline during acquisition
(Figure 2b0), although under these conditions tPA-treated
animals displayed lower CPP score at the end of the training
period (as already shown in Figure 1b, F(11,60)¼ 35.185;
po0.0001).
Figure 1 LV-tPA enhances amphetamine-induced place preference. Animals were injected with either LV-GFP, LV-tPA, or LV-siRNAs. Rats were
habituated to the CPP cages for 3 days and tested for pre-conditioning; then they were trained for CPP using amphetamine (5mg/kg) or 0.9% saline (1ml/
kg) for 6 days and tested for post-conditioning (a and b). Six groups of animals received 5% sucrose in the drinking water during conditioning (CPP
acquisition) (‘No Doxy’, a), six groups received water supplemented with 5% sucrose and 0.02% doxycycline during conditioning (‘Doxy in Acquisition’, b),
and doxycycline was removed 24 h prior to post-conditioning. Values indicate means±SEM. *po0.05, **po0.01, ***po0.005 compared with pre-
conditioning (expression); #po0.05, ##po0.01, ###po0.005 compared with amphetamine-conditioned animals; Øpo0.05, ØØpo0.01 compared with LV-
tPA injected animals; dpo0.05 compared with LV-tPA injected animals; $po0.05 compared with animals fed doxycycline during conditioning (acquisition).
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Priming with Low Dose of Amphetamine, but not Saline,
Reinstates Amphetamine-Induced Place Preference by
LV-tPA After Extinction
At the end of the extinction period, all animals were injected
with saline and tested for CPP, but no place preference was
observed in all the groups of animals (data not shown;
F(11,60)¼ 0.715; p40.719). Thereafter, animals were given
one single injection of amphetamine (2mg/kg, i.p.) and
tested for CPP during 20min (Figure 3a and b). This
priming injection stimulated place preference and all
groups of animals immediately recapitulated the CPP score
observed at the end of the training sessions (compare
day 10; Figure 1, F(11,60)¼ 79.857; po0.0001). Animals
that had been trained with saline during the conditioning
phase, displayed no place preference in all the groups
(F(5,30)¼ 1.047; p40.409), but for animals trained with
amphetamine during conditioning, despite drug withdrawal
for 12 days the CPP scores observed at the post-condition-
ing session were immediately recovered upon this single
priming drug injection, whatever the feeding regimen
(Figure 3, F(5,30)¼ 140.54; po0.0001).
LV-tPA Maintained Amphetamine-Induced Place
Preference
Animals were injected with LV-GFP, LV-tPA, or LV-siRNAs
and trained for CPP as described above. After CPP
monitoring on day 10, rats were placed back in their home
Figure 2 LV-tPA-mediated delayed extinction of Amphetamine-induced place preference. Animals were injected with either LV-GFP, LV-tPA, or
LV-siRNAs and trained with daily injections of. saline or amphetamine (see Materials and Methods). After CPP monitoring on day 10, they were placed daily
into the setup for 20 min/day for 12 days, but drug or saline were not injected during this extinction period. (a) Saline-injected animals fed 5% sucrose
regimen during acquisition; (b) saline-injected animals fed doxycycline regimen during acquisition; (c) amphetamine-injected animals fed 5% sucrose regimen
during acquisition; and (d) amphetamine-injected animals fed doxycycline regimen during acquisition. Values indicate means±SEM.
Figure 3 Low dose of amphetamine but not saline priming reinstates amphetamine-induced place preference by LV-tPA after extinction. Animals were
injected with LV-GFP, LV-tPA, or LV-siRNAs and trained for CPP as in Figure 1. After CPP monitoring on day 10, rats were placed daily into the setup for
20min during 12 days. Animals were then given one single injection of 0.9% saline (1ml/kg, i.p.) or amphetamine (0.5mg/kg, i.p.) and tested for CPP
during 20min. Values indicate means±SEM. *po0.05, **po0.01, ***po0.005 compared with saline-primed animals. #po0.05, ##po0.01, ###po0.005
compared with amphetamine-conditioned animals; Øpo0.05, ØØpo0.01 compared with LV-tPA-injected animals; dpo0.05 compared with LV-tPA-
injected animals; $po0.05 compared with animals fed doxycycline during conditioning (acquisition).
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cages without testing or injection for 5 weeks. After this
withdrawal period, animals were placed into the CPP setup
and submitted to a final test for CPP during 20min, with no
injection of either saline or amphetamine. Placed into this
environment, animals immediately displayed CPP scores
almost identical to those achieved at the end of the training
period (F(11,60)¼ 74.177; po0.0001). No significant differ-
ence was observed for each respective group between CPP
scores observed in Figures 1, 4a and b, respectively (within
group comparison, p40.134). Under these conditions, tPA-
overexpressing animals that had been conditioned with
amphetamine again spent 485% of the time in the drug-
associated compartment (F(3,20)¼ 115.18; po0.0001),
whereas if tPA expression had been downregulated during
conditioning (either with doxycycline, that is, downregula-
ting ectopic expression, or with siRNAs, that is, suppressing
endogenous expression), the time spent in the drug-
associated compartment was considerably reduced
(F(3,20)¼ 24.65; po0.01). In all cases, scores were identical
to those obtained immediately after conditioning.
Immunocytochemistry
Animals treated with LV-GFP, LV-tPA, or LV-siRNAs were
decapitated and brains were removed for immunocyto-
chemistry. As shown in Figure 5, lentivirus treatment led to
strong overexpression of ectopic tPA in brains from animals
given normal regimen, as detected using 6His monoclonal
antibody, whereas after a doxycycline regimen, tPA in the
NAc was reduced to levels similar to those found in control
animals (ie, treated with LV-GFP) (Figure 5). On the other
hand, animals treated with LV-siRNA display no tPA
expression in the NAc, indicating almost full suppression
of the gene (Figure 5). These data were further confirmed by
zymography, which showed that the active enzyme was fully
absent in the NAc from animals treated with LV-siRNAs,
but was present in the NAc of LV-tPA-treated animals (data
not shown). tPA activity was enhanced in the absence of
doxycycline, and upon cocaine priming, but was absent
when animals were injected LV-GFP or LV-siRNAs, or when
animals were given doxycycline in the drinking water
during acquisition, and also when animals received saline
injection for priming. This correlates with behavioral
observations and indicates that the proteolytic activity is
probably necessary for the acquisition of CPP.
DISCUSSION
The data in this study suggest that overexpression of tPA in
the NAc strongly affects CPP, and may also delay CPP
extinction. Ectopic overexpression of tPA in the NAc was
achieved by administration of LV-tPA, which was active
during the acquisition phase of place preference conditioning
using amphetamine as an unconditioned stimulus. The
Figure 4 LV-tPA maintained amphetamine-induced place preference. Animals were injected with LV-GFP, LV-tPA, or LV-siRNAs and trained for CPP as
in Figure 1. After CPP monitoring on day 10, rats were placed back in their home cages without testing or injection during 5 weeks. After this period,
animals were submitted to a final test for CPP during 20min. Values indicate means±SEM. #po0.05, ##po0.01 compared with amphetamine-conditioned
animals; Øpo0.05, ØØpo0.01 compared with LV-tPA-injected animals; dpo0.05 compared with LV-tPA injected animals; $po0.01 compared with animals
fed doxycycline during conditioning (acquisition).
Figure 5 tPA immunohistochemistry at the site of stereotactic injection
of LV-GFP, uPA expressing lentivirus (LV-uPA), or LV-siRNAs in the NAc.
Animals were killed at the end of the experiment, and brains were
dissected out and processed for immunohistochemistry (see section
Materials and Methods for details). Rats were injected with LV-GFP (upper
panels), LV-uPA (middle panels), or LV-siRNAs (lower panels). Rats were
treated with normal doxycycline-free regimen (left panels) or with 0.02%
doxycycline during acquisition (right panels). Magnification:  60.
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results showed that tPA-overexpressing animals spent more
than 87% of the time in the amphetamine-associated
compartment, compared with 60% preference displayed by
conditioned animals given the control infusion, LV-GFP.
When ectopic expression of tPA was inhibited by doxycycline
throughout the acquisition period, LV-tPA-treated animals
failed to show augmented CPP. These latter results confirmed
that the LV-tPA needed to be active, and producing tPA, in
order to promote the development of greater preference to an
amphetamine-associated context.
While the foregoing results involved the supplementation
of endogenous tPA with virally delivered tPA, an additional
group of animals provided the converse condition of
lowering endogenous tPA levels using LV-siRNA treatment
that targets tPA mRNA. This treatment was also localized to
the NAc and revealed effects opposite of those obtained with
LV-tPA treatment. That is, amphetamine-conditioned
animals given LV-siRNA during the acquisition phase
developed significant reduction in preference to the drug-
associated context. In spending significantly less time in the
drug-associated chamber than LV-GFP controls (and
LV-tPA animals), these data suggest that reducing endo-
genous levels of tPA promotes the development of a
conditioned aversion. Moreover, this is a learned response,
given that extinction trials resulted in a reduction of context
avoidance in LV-siRNA animals previously conditioned
with amphetamine.
Whether the latter observations are confined to stimulant
drugs, remains to be determined. Conceptually, it is relevant
that low or impaired production of tPA in mice was shown
to enhance emotional reactivity to psychogenic stressors
and impair learning (Ammassari-Teule et al, 2001; Madani
et al, 2003; Pawlak et al, 2005). Moreover, stimulants, such
as amphetamine, are sympathomimetics that produce
significant elevations in various central and peripheral
parameters of physiological arousal (eg, activation of the
noradrenergic system). Therefore, it could be hypothesized
that reductions in tPA reduce the threshold for arousal in
response to CNS stimulants, reducing their reinforcing
efficacy for drug-seeking behavior. This is conceivable in
light of studies of tPA-deficient mice showing greater
locomotor responses to low doses of cocaine, when
compared with similarly treated wild-type mice (Ripley
et al, 1999). In addition, using a self-administration
paradigm, tPA-knockout mice showed less responding for
morphine, as compared with wild-type controls (Yan et al,
2007), suggesting that a deficiency in tPA renders drugs of
abuse less rewarding and/or reinforcing. The present
studies are not inconsistent with this possibility, although
further studies are required to clarify precisely what
motivational and cognitive mechanisms are being affected
by tPA modulation using the lentivirus system.
The present study also tested extinction over a 12-day
period subsequent to the development of CPP in LV-tPA
animals. The results suggested that extinction was delayed
in amphetamine-conditioned LV-tPA rats, although it
should be emphasized that the starting preference for these
animals was substantially higher than for the amphetamine-
treated LV-GFP and LV-siRNA groups. Nevertheless, it is
notable that after 1 week of un-reinforced trials, the
previously conditioned LV-tPA animals are still showing a
high preference for the conditioned context, which by this
time was well above the equivalent preference for both
chambers shown by all other groups. This may demonstrate
that the original CS-UCS association between context and
amphetamine treatment is quite strong (as evident on day 1;
Figure 2, bottom panel), and sufficiently stable to prevent a
rapid return to preconditioning levels of preference. More-
over, upon priming with a small dose of amphetamine, the
LV-tPA group reverted to the greater preference to the
drug-associated context, when compared with the pre-
viously conditioned LV-GFP group receiving a similar
priming dose of amphetamine. This indicates that eleva-
tions in tPA during acquisition of CPP create very strong
learning associations that can re-enlist response biases to
pre-extinction levels. This observation is of obvious clinical
relevance given that relapse to drug-seeking behavior is a
recurring and intractable problem.
It is also important to note that tPA appears to play an
important role more in acquisition of amphetamine-
induced CPP, rather than in its expression. Indeed, even
though the active enzyme is overexpressed after acquisition,
eventual extinction is observed. In addition, we have shown
that tPA is induced upon chronic drug administration (Bahi
and Dreyer, 2007), in agreement with findings from other
groups (Nagai et al, 2005, 2006). Nicotine increased tPA
protein levels and promoted the release of tPA into the
extracellular space in the NAc. Furthermore, our previous
studies have shown similar effects for uPA upon cocaine
injection, whereas inhibition of uPA impairs reconsolida-
tion of the cocaine-induced place preference even after
extinction and while animals are under the influence of
cocaine during reinstatement testing, indicating that uPA
may mediate cocaine-associated contextual memory (Bahi
and Dreyer, 2007).
The present findings are consistent with the view that tPA
activator plays a key role in neuroplasticity and is a
neuromodulator in the CNS (Yamada et al, 2005). More-
over, as previously mentioned, the tPA–plasmin system is
involved in the rewarding effects of drugs of abuse (eg,
morphine), possibly through regulation of dopamine release
in the NAc (Nagai et al, 2004, 2005, 2006; Ito et al, 2006,
2007; Yan et al, 2007). Indeed, similar to the present
findings involving the use of LV-siRNA, tPA-knockout mice
showed a reduction in morphine-, methamphetamine-, and
nicotine-induced CPP and locomotor sensitization (Nagai
et al, 2004, 2005, 2006; Ito et al, 2006, 2007; Yan et al, 2007).
Furthermore, exogenous recombinant human tPA or
plasmin restored the defect of morphine-induced dopamine
release in the NAc and hyperactivity in tPA-knockout mice
(Nagai et al, 2004). No significant difference in food-
reinforced operant behavior was observed between tPA-
knockout and wild-type control mice, but tPA-knockout
mice showed an increase in morphine self-administration,
suggesting that tPA is critically involved in the reinforcing
properties of morphine in mice (Yan et al, 2007). The
present results are consistent with these previous findings
and the conclusion that the tPA system may represent a
potential target in the therapeutic treatment of drug
addiction.
Drug addiction exploits learning and memory systems
(O’Brien et al, 1992; Bonci and Malenka, 1999; Thomas et al,
2000; Wise, 2000; Hyman, 2005). Memories for events,
places, foods, behaviors, and emotions play an important
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role in addiction. Persistent drug-seeking/taking behavior
involves the consolidation and retention of information
associated with the psychopharmacologic properties of
drugs (Wright and Harding, 2004). Reconsolidation serves
to maintain, strengthen, or modify memories. Specifically,
retrieval of previously consolidated memory traces may
induce an additional activity-dependent labile period
during which the memory can be modified. Furthermore,
chronic drug exposure results in neuronal plasticity,
as exemplified by morphological changes in neurons
(Robinson and Kolb, 1999; Robinson et al, 2001). Conse-
quently, molecules such as tPA that are involved in
plasticity may influence acquisition and/or reconsolidation
of drug-related information via these mechanisms.
Understanding the molecular mechanisms of reconsoli-
dation may provide crucial insights into the behaviors of
normal individuals and into psychiatric disorders such as
addiction that are characterized by exceptionally strong and
salient emotional memories. Anxiolytic and amnestic agents
have been proposed as useful tools in eliminating memories
after retrieval; for example, benzodiazepines have recently
been shown to disrupt reconsolidation of contextual fear in
rats (Tronson and Taylor, 2007). As an alternative to these
strategies, our studies demonstrate the potential clinical
relevance of focusing attention on the plasminogen system.
Using the lentivirus system, we showed that tPA may be
involved in learning and amphetamine-associated contex-
tual memory. Although we observed a conditioned aversion
when silencing endogenous tPA with LV-siRNA, our studies
support the notion that memory and/or retrieval cues for
drug-associated contexts may be diminished by pharmaco-
logical lowering of tPA. This may lead to development of
new treatment strategies for human addiction.
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